catheter based renal denervation; new treatment option; pleiotropic effects; Symplicity; treatment resistant hypertension
Indexed keywords
HYPERTENSION;
KIDNEY DENERVATION;
NOTE;
ANTIHYPERTENSIVE AGENTS;
CLINICAL TRIALS AS TOPIC;
COMBINED MODALITY THERAPY;
DEVICE APPROVAL;
DRUG APPROVAL;
DRUG RESISTANCE;
DRUG THERAPY, COMBINATION;
GERMANY;
HUMANS;
HYPERTENSION;
MEDICATION ADHERENCE;
RENAL ARTERY;
SYMPATHECTOMY;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension
Brandt MC, Mahfoud F, Reda S et al. Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension. J Am Coll Cardiol: 2012; 59 901 909
Renal sympathetic denervation in patients with treatment-resistant hypertension (the symplicity htn-2 trial)
Esler MD, Krum H, Sobotka PA et al. Renal sympathetic denervation in patients with treatment-resistant hypertension (the symplicity htn-2 trial). Lancet: 2010; 376 1903 1909
Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension
Mahfoud F, Schlaich M, Kindermann I et al. Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension. Circulation: 2011; 123 1940 1946
Interventionelle renale Sympathikusdenervation zur Behandlung der therapieresistenten Hypertonie
Mahfoud F, Vonend O, Bruck H et al. Interventionelle renale Sympathikusdenervation zur Behandlung der therapieresistenten Hypertonie. Dtsch Med Wochenschr: 2011; 136 2418 2424
Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea
Witkowski A, Prejbisz A, Florczak E et al. Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea. Hypertension: 2011; 58 559 565